Empowered Funds’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $28.5M | Buy |
225,845
+30,382
| +16% | +$4M | 0.15% | 130 |
|
|
2026
Q1 | $27.2M | Buy |
+195,463
| New | +$27.4M | 0.17% | 108 |
|
|
2025
Q4 | – | Sell |
-149,751
| Closed | -$16.6M | – | 1346 |
|
|
2025
Q3 | $16.6M | Sell |
149,751
-70,378
| -32% | -$8M | 0.17% | 111 |
|
|
2025
Q2 | $24.4M | Buy |
220,129
+625
| +0.3% | +$66.5K | 0.28% | 62 |
|
|
2025
Q1 | $24.6M | Sell |
219,504
-75
| -0% | -$7.74K | 0.35% | 40 |
|
|
2024
Q4 | $20.3M | Buy |
219,579
+78,657
| +56% | +$7.08M | 0.3% | 46 |
|
|
2024
Q3 | $11.8M | Sell |
140,922
-103,596
| -42% | -$7.9M | 0.19% | 103 |
|
|
2024
Q2 | $16.8M | Buy |
244,518
+48,792
| +25% | +$3.26M | 0.29% | 47 |
|
|
2024
Q1 | $14.3M | Buy |
195,726
+75,463
| +63% | +$5.8M | 0.26% | 69 |
|
|
2023
Q4 | $9.74M | Buy |
120,263
+47,982
| +66% | +$3.73M | 0.24% | 71 |
|
|
2023
Q3 | $5.42M | Buy |
72,281
+45,916
| +174% | +$3.53M | 0.16% | 152 |
|
|
2023
Q2 | $2.03M | Sell |
26,365
-15,518
| -37% | -$1.24M | 0.07% | 388 |
|
|
2023
Q1 | $3.48M | Buy |
+41,883
| New | +$3.47M | 0.2% | 141 |
|
|
2022
Q1 | – | Sell |
-66,876
| Closed | -$4.86M | – | 263 |
|
|
2021
Q4 | $4.86M | Buy |
+66,876
| New | +$4.61M | 0.55% | 69 |
|
|
2020
Q4 | – | Sell |
-44,117
| Closed | -$2.79M | – | 184 |
|
|
2020
Q3 | $2.79M | Buy |
44,117
+9,396
| +27% | +$652K | 0.87% | 37 |
|
|
2020
Q2 | $2.67M | Sell |
34,721
-3,147
| -8% | -$241K | 1.03% | 18 |
|
|
2020
Q1 | $2.46M | Hold |
37,868
| – | – | 0.89% | 48 |
|
|
2019
Q4 | $2.46M | Buy |
37,868
+4,119
| +12% | +$268K | 0.89% | 48 |
|
|
2019
Q3 | $2.14M | Buy |
33,749
+100
| +0.3% | +$6.54K | 0.93% | 39 |
|
|
2019
Q2 | $2.27M | Sell |
33,649
-5,737
| -15% | -$377K | 0.95% | 26 |
|
|
2019
Q1 | $2.56M | Buy |
39,386
+5,360
| +16% | +$356K | 0.92% | 20 |
|
|
2018
Q4 | $2.13M | Sell |
34,026
-9,146
| -21% | -$639K | 0.9% | 28 |
|
|
2018
Q3 | $3.31M | Sell |
43,172
-448
| -1% | -$33.8K | 0.98% | 15 |
|
|
2018
Q2 | $3.07M | Buy |
43,620
+2,558
| +6% | +$181K | 0.97% | 20 |
|
|
2018
Q1 | $3.07M | Buy |
41,062
+10,163
| +33% | +$808K | 1.12% | 26 |
|
|
2017
Q4 | $2.21M | Buy |
30,899
+9,377
| +44% | +$712K | 1.11% | 39 |
|
|
2017
Q3 | $1.74M | Sell |
21,522
-3,763
| -15% | -$288K | 1.13% | 40 |
|
|
2017
Q2 | $1.79M | Buy |
25,285
+2,788
| +12% | +$186K | 1.45% | 10 |
|
|
2017
Q1 | $1.53M | Buy |
+22,497
| New | +$1.58M | 1.57% | 29 |
|
Other funds holding GILD
Empowered Funds's GILD Position: Q2 2026 in Review
Empowered Funds increased its Gilead Sciences (GILD) stake by 16% in Q2 2026, buying an estimated $4M and bringing the position to 225,845 shares worth $28.5M. The position accounts for 0.15% of the portfolio, ranked #130.
Empowered Funds first reported a position in GILD in Q1 2017 and has held it in 29 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Empowered Funds held 225,845 shares of Gilead Sciences worth $28.5M as of Q2 2026.
- Empowered Funds bought 30,382 Gilead Sciences shares in Q2 2026, an estimated $4M.
- Gilead Sciences made up 0.15% of Empowered Funds's portfolio in Q2 2026, its #130 holding.
- Empowered Funds first reported a position in Gilead Sciences in Q1 2017 and has held it in 29 quarters since.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.